Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Telstar Provides Safety Cabinets to NUI Galway’s Biomedical Research Facility

Published: Wednesday, March 19, 2014
Last Updated: Wednesday, March 19, 2014
Bookmark and Share
The new, recently inaugurated research facility, which is directed towards cancer research, regenerative medicine and glycosciences, takes its place as one of five global hubs in the medtech sector.

A complete package comprising 63 cabinets developed by Telstar has been delivered to the new Biomedical Science Research Facility at the National University of Ireland in Galway (NUI Galway).

The activities of NUI Galway’s Biomedical Science Research Facility are specifically directed towards cancer research, regenerative medicine and glycosciences.

The cabinets provided by Telstar have been designed considering specific bioprocessing applications in the medical and clinical research field.

The suite of cabinets provided by Telstar represent a new generation of innovative biological safety cabinets designed to work in research environments such as tissue culture suites, radiochemistry, flow cytometry, screening core, sample preparation and biomimic areas.

The cabinets developed by Telstar for NUI Galway’s Biomedical Science Research Facility are more compact and optimize the usable work area in laboratories with limited space.

The cabinet design offers a body 20% smaller than the market average while maintaining standard work space.

Intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3, the new range of Telstar safety cabinets offers an ergonomic design that adapts easily to small spaces, especially in laboratories with low ceilings and where several pieces of equipment need to be used in the same area.

Of the total of cabinets designed by Telstar, 57 of them correspond to Telstar Bio II Advance range, the class II cabinet designed in accordance EN12469 standard, and 6 units of EF B range of class II B2 cabinets in accordance with NSF49 standard.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Immunotherapy Reduces Rheumatoid-Linked Cardiovascular Risk
Study shows combination of two extra-low dose anticytokines reduces disease activity and cardiovascular events.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
Sanofi Working on Zika Vaccine with U.S. Army
Sanofi is working in conjunction with the U.S. Army to develop possible Zika vaccine at faster rate following research agreement.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!